Ascorbic Acid Deficiency
Recent clinical, regulatory, research and industry developments relating to this disease.
Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Research-associated treatments
Drugs and agents co-studied with this disease across the research literature — associative, not necessarily established treatments. Number shows shared papers.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Leading journals1
- Nutrients2
Leading researchers8
- Doseděl M1
- Javorská L1
- Jirkovský E1
- Krčmová LK1
- Macáková K1
- Marquez D1
- Mercolini L1
- Mladěnka P1
Affiliations (unnormalised)6
- Alma Mater Studiorum-University of Bologna1
- Centre for Human Psychopharmacology1
- Charles University1
- Department of Clinical Biochemistry and Diagnostics1
- Department of Social and Clinical Pharmacy1
- Laboratory of Toxicology1
Reference
Authoritative identity, definition & identifiers.
A condition due to a dietary deficiency of ascorbic acid (vitamin C), characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into SCURVY in young children fed unsupplemented cow's milk exclusively during their first year. It develops also commonly in chronic alcoholism. (Cecil Textbook of Medicine, 19th ed, p1177)
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.